Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis
暂无分享,去创建一个
A. Martini | P. Quartier | L. Goffin | A. Grom | M. Hofer | N. Ruperto | K. Abrams | T. Kallinich | K. Schikler | K. Lheritier | K. Marzan | M. Erguven | C. Gaillez | D. Lovell | H. Brunner